Close
Smartlab Europe
Achema middle east

News

A $400 Bn Pharmaceutical Packaging Market Is Up For Grabs

Advancements when it comes to manufacturing, demand in terms of sustainability, as well as an ongoing surge in terms of worldwide healthcare requirements, are in a way collectively pushing the pharmaceutical packaging market towards an unprecedented growth level. As per...

Enhancing Cell Count: Unveiling the Power of Precision in Cell Counting Technology in Medicine

Cell counting technology in medicine has evolved significantly, driven by the need for precise analysis of diverse cell characteristics. Cell count, cell type, size variability, and viability assessment are critical in clinical and research applications. The precision of cell...

5 Trends In Pharma Packaging That Will Continue After 2025

Because of new ideas, concerns about safety for consumers, and government rules, the pharmaceutical business is about to enter a new era in packing. As we get closer to 2025 and beyond, a number of important trends will change...

AI Boost In Pharma: Enhancing Care With Human-Led Solutions

Digital tools are changing how the pharmacy business can meet the needs of consumers and healthcare workers (HCPs). The key is to use a human led, AI-powered method that blends the best of human knowledge and cutting edge artificial...

PhotonPharma Secures $2.5 Million in Seed Funding to Advance Clinical Trial for Ovarian Cancer Treatment

PhotonPharma, a cutting-edge biopharmaceutical company based in Fort Collins, Colorado, is pleased to announce the successful closing of a $2.5 million seed financing round. This vital funding will support the Phase I clinical trial of Innocell™, an innovative therapy...

BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases

BioVaxys Technology Corp. highlights the potential of its novel lipid-in-oil delivery platform, DPX™, across multiple infectious disease studies and announces its plans for partnering and further development. BioVaxys' DPX™ technology is a patented delivery platform that can incorporate a range...

Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program

Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen's DNA-encoded...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »